Each year, 8,000 new cases of Parkinson’s disease are diagnosed in France. And between 100,000 and 120,000 people are affected in France by this so-called neurodegenerative disease, which affects the nervous system and which in the long term can lead to dementia. Unfortunately, for the time being, no treatment can really contain the disease, nor its progression. A new study could well give a glimmer of hope, since it suggests the possibility of really curing the disease thanks to the discovery of a new treatment.
What does the new study tell us?
Parkinson’s disease is part of the group of so-called orphan diseases. And this is due to the fact that no treatment to date can cure the disease. Only a combination of molecules can slow its progression, while reducing clinical manifestations or complications.
However, until then no one could have said what is the origin of Parkinson’s. If this is an alteration in the balance of release of neurotransmitters. The new study tells us for the first time the origin of the disease, which is believed to be linked to the protein alpha-synuclein.
By the way, what is Parkinson’s disease?
To put it simply, it is a disease that is part of the group of so-called neurodegenerative diseases. These have the pathological mechanism of reaching the neurological system, destroying the neurons gradually.
It manifests itself in various ways. Although the most common manifestation is the resting tremor.
Treatment through discovery
Published in the journal Nature Communications, the study highlights the appearance of the first symptoms of the disease and the massive release of the protein alpha-synuclein. Normally this protein is not produced by the body.
This led to the following conclusion: if researchers manage to stem the production or release of this protein, the disease is over. It is therefore the fight of this decade, which in parentheses, got off to a bad start because of the coronavirus pandemic.
–
